246 related articles for article (PubMed ID: 12079242)
1. The precursors of malignant melanoma.
Crowson AN; Magro CM; Sanchez-Carpintero I; Mihm MC
Recent Results Cancer Res; 2002; 160():75-84. PubMed ID: 12079242
[TBL] [Abstract][Full Text] [Related]
2. Dermatological perspectives of malignant melanoma.
Swetter SM
Surg Clin North Am; 2003 Feb; 83(1):77-95, vi. PubMed ID: 12691451
[TBL] [Abstract][Full Text] [Related]
3. Precursors to skin cancer.
Sober AJ; Burstein JM
Cancer; 1995 Jan; 75(2 Suppl):645-50. PubMed ID: 7804989
[TBL] [Abstract][Full Text] [Related]
4. Lentigo maligna and lentigo maligna melanoma.
Cohen LM
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):913. PubMed ID: 9204053
[No Abstract] [Full Text] [Related]
5. Lentigo maligna and lentigo maligna melanoma.
Johr RH; Stolz W
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):512. PubMed ID: 9308580
[No Abstract] [Full Text] [Related]
6. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus.
King R; Page RN; Googe PB; Mihm MC
Mod Pathol; 2005 Oct; 18(10):1397-401. PubMed ID: 15976811
[TBL] [Abstract][Full Text] [Related]
7. Dermatologic lesions and risk for cancer.
Lanssens S; Ongenae K
Acta Clin Belg; 2011; 66(3):177-85. PubMed ID: 21837924
[TBL] [Abstract][Full Text] [Related]
8. Precursor lesion of malignant melanoma in xeroderma pigmentosum: reflections about solar lentigo as the precursor.
Hedblad MA; Borglund E
J Am Acad Dermatol; 1995 Apr; 32(4):680-2. PubMed ID: 7755744
[No Abstract] [Full Text] [Related]
9. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
[TBL] [Abstract][Full Text] [Related]
10. Unstable solar lentigo: A defined separate entity.
Byrom L; Barksdale S; Weedon D; Muir J
Australas J Dermatol; 2016 Aug; 57(3):229-34. PubMed ID: 26832231
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
12. [Intra-epithelial melanocytic neoplasia (MIN), a new term proposed for dysplastic melanocytic lesions].
Collina G
Pathologica; 1997 Apr; 89(2):196-8. PubMed ID: 9411373
[No Abstract] [Full Text] [Related]
13. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
14. Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.
Zoutendijk J; Tio D; Koljenovic S; van den Bos RR
Br J Dermatol; 2019 Aug; 181(2):383-384. PubMed ID: 30716164
[No Abstract] [Full Text] [Related]
15. Malignant melanoma: differential diagnosis of pigmented lesions.
Le AD; Fenske NA; Glass LF; Messina JL
J Fla Med Assoc; 1997 Mar; 84(3):166-74. PubMed ID: 9143168
[TBL] [Abstract][Full Text] [Related]
16. Histologic predictors of invasion in partially biopsied lentigo maligna melanoma.
Aouidad I; Fargeas C; Romero P; Sei JF; Chaussade V; Beauchet A; Clerici T; Zimmermann U; Saiag P; Funck-Brentano E
J Am Acad Dermatol; 2019 Apr; 80(4):1150-1152. PubMed ID: 30879481
[No Abstract] [Full Text] [Related]
17. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
[TBL] [Abstract][Full Text] [Related]
18. Melanoma and nevi: detection and diagnosis.
Choi JN; Hanlon A; Leffell D
Curr Probl Cancer; 2011; 35(4):138-61. PubMed ID: 21911179
[No Abstract] [Full Text] [Related]
19. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
Flotte TJ; Mihm MC
Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
[TBL] [Abstract][Full Text] [Related]
20. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
